Asia-Pacific Insulin Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Insulin Market – By Type

1.3.2 APAC Insulin Market – By Country

2. APAC Insulin Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Insulin Market – Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.2.1 Expert Opinion

5. APAC Insulin Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Incidence of Diabetes

5.1.2 Rapid Technological Developments in Insulin Delivery Devices by Major Players

5.2 Market Restraints

5.2.1 Risks Associated with Insulin Delivery Devices

5.3 Market Opportunities

5.3.1 Insufficient Competition from Biosimilars

5.4 Future Trends

5.4.1 Regeneration of Diabetic Pancreas with Advanced Transplants

5.5 Impact Analysis

6. Insulin Market– APAC Analysis

6.1 APAC Insulin Market Revenue Forecast and Analysis

7. APAC Insulin Market Analysis – By Type

7.1 Overview

7.2 APAC Insulin Market Revenue Share, by Type (2021 and 2028)

7.3 Long Acting Insulin

7.3.1 Overview

7.3.2 Long Acting Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Levemir

7.3.2.1.1 Overview

7.3.2.1.2 Levemir: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Lantus

7.3.2.2.1 Overview

7.3.2.2.2 Lantus: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Basaglar

7.3.2.3.1 Overview

7.3.2.3.2 Basaglar: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.4 Tresiba

7.3.2.4.1 Overview

7.3.2.4.2 Tresiba: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Rapid Acting Insulins

7.4.1 Overview

7.4.2 Rapid Acting Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Novolog

7.4.2.1.1 Overview

7.4.2.1.2 Novolog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Humalog

7.4.2.2.1 Overview

7.4.2.2.2 Humalog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.3 Admelog

7.4.2.3.1 Overview

7.4.2.3.2 Admelog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.4 Others

7.4.2.4.1 Overview

7.4.2.4.2 Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Short Acting Insulins and Traditional Human Insulins

7.5.1 Overview

7.5.2 Short Acting Insulins and Traditional Human Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1 Novolin R

7.5.2.1.1 Overview

7.5.2.1.2 Novolin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Humulin R

7.5.2.2.1 Overview

7.5.2.2.2 Humulin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Insuman

7.5.2.3.1 Overview

7.5.2.3.2 Insuman: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.4 Others

7.5.2.4.1 Overview

7.5.2.4.2 Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Concentrated Insulins and Combination Insulins

7.6.1 Overview

7.6.2 Concentrated Insulins and Combination Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.1 NovoMix

7.6.2.1.1 Overview

7.6.2.1.2 NovoMix: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.2 Ryzodeg

7.6.2.2.1 Overview

7.6.2.2.2 Ryzodeg: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.3 Xultophy

7.6.2.3.1 Overview

7.6.2.3.2 Xultophy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.4 Soliqua/Suliqua

7.6.2.4.1 Overview

7.6.2.4.2 Soliqua/Suliqua: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Biosimilar Insulins

7.7.1 Overview

7.7.2 Biosimilar Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.1 Insulin Glargine

7.7.2.1.1 Overview

7.7.2.1.2 Insulin Glargine: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.2 Human Insulin

7.7.2.2.1 Overview

7.7.2.2.2 Human Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.8 Glucagon-like peptide-1 (GLP-1)

7.8.1 Overview

7.8.2 Glucagon-like peptide-1 (GLP-1): Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.9 Pens and Needles

7.9.1 Overview

7.9.2 Pens and Needles: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.10 Others

7.10.1 Overview

7.10.2 Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8. APAC Insulin Market – Country Analysis

8.1 Overview

8.1.1 Asia Pacific: Insulin Market, by Country, 2022 & 2028 (%)

8.1.1.1 China: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.1.1 China: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.1.2 China: Insulin Market, by Type, 2019–2028 (US$ Million)

8.1.1.1.2.1 China: Insulin Market, by Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.1.2.2 China: Insulin Market, by Rapid Acting Insulins, 2019–2028 (US$ Million)

8.1.1.1.2.3 China: Insulin Market, by Short Acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.1.2.4 China: Insulin Market, by Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.1.2.5 China: Insulin Market, by Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.1.2 Japan: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.2.1 Japan: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.2.2 Japan: Insulin Market, by Type, 2019–2028 (US$ Million)

8.1.1.2.2.1 Japan: Insulin Market, by Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.2.2.2 Japan: Insulin Market, by Rapid Acting Insulins, 2019–2028 (US$ Million)

8.1.1.2.2.3 Japan: Insulin Market, by Short Acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.2.2.4 Japan: Insulin Market, by Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.2.2.5 Japan: Insulin Market, by Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.1.3 India: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.3.1 India: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.3.2 India: Insulin Market, by Type, 2019–2028 (US$ Million)

8.1.1.3.2.1 India: Insulin Market, by Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.3.2.2 India: Insulin Market, by Rapid Acting Insulins, 2019–2028 (US$ Million)

8.1.1.3.2.3 India: Insulin Market, by Short Acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.3.2.4 India: Insulin Market, by Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.3.2.5 India: Insulin Market, by Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.1.4 Australia: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.4.1 Australia: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.4.2 Australia: Insulin Market, by Type, 2019–2028 (US$ Million)

8.1.1.4.2.1 Australia: Insulin Market, by Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.4.2.2 Australia: Insulin Market, by Rapid Acting Insulins, 2019–2028 (US$ Million)

8.1.1.4.2.3 Australia: Insulin Market, by Short Acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.4.2.4 Australia: Insulin Market, by Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.4.2.5 Australia: Insulin Market, by Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.1.5 South Korea: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.5.1 South Korea: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.5.2 South Korea: Insulin Market, by Type, 2019–2028 (US$ Million)

8.1.1.5.2.1 South Korea: Insulin Market, by Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.5.2.2 South Korea: Insulin Market, by Rapid Acting Insulins, 2019–2028 (US$ Million)

8.1.1.5.2.3 South Korea: Insulin Market, by Short Acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.5.2.4 South Korea: Insulin Market, by Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.5.2.5 South Korea: Insulin Market, by Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.1.6 Rest of Asia Pacific: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.6.1 Rest of Asia Pacific: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.6.2 Rest of Asia Pacific: Insulin Market, by Type, 2019–2028 (US$ Million)

8.1.1.6.2.1 Rest of Asia Pacific: Insulin Market, by Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.6.2.2 Rest of Asia Pacific: Insulin Market, by Rapid Acting Insulins, 2019–2028 (US$ Million)

8.1.1.6.2.3 Rest of Asia Pacific: Insulin Market, by Short Acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.6.2.4 Rest of Asia Pacific: Insulin Market, by Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.6.2.5 Rest of Asia Pacific: Insulin Market, by Biosimilar Insulins, 2019–2028 (US$ Million)

9. APAC Insulin Market–Industry Landscape

9.1 Overview

9.2 Organic Developments

9.2.1 Overview

9.3 Inorganic Developments

9.3.1 Overview

10. Company Profile

10.1 Eli Lilly and Company

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Products and Services

10.1.4 Financial Overview

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Novo Nordisk A/S

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Products and Services

10.2.4 Financial Overview

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 Biocon

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Products and Services

10.3.4 Financial Overview

10.3.5 SWOT Analysis

10.3.6 Key Developments

10.4 Wockhardt

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Products and Services

10.4.4 Financial Overview

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 Adocia

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Products and Services

10.5.4 Financial Overview

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 GlaxoSmithKline plc.

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Products and Services

10.6.4 Financial Overview

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 Sanofi

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Products and Services

10.7.4 Financial Overview

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 Pfizer Inc.

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Products and Services

10.8.4 Financial Overview

10.8.5 SWOT Analysis

10.8.6 Key Developments

10.9 Merck & Co., Inc.

10.9.1 Key Facts

10.9.2 Business Description

10.9.3 Products and Services

10.9.4 Financial Overview

10.9.5 SWOT Analysis

10.9.6 Key Developments

10.10 Tonghua Dongbao Pharmaceutical Co., Ltd.

10.10.1 Key Facts

10.10.2 Business Description

10.10.3 Products and Services

10.10.4 Financial Overview

10.10.5 SWOT Analysis

10.10.6 Key Developments

11. Appendix

11.1 About The Insight Partners

11.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Insulin Market, Revenue and Forecast, 2019–2028 (US$ Million)

Table 2. China: Insulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. China: Insulin Market, by Long Acting Insulin – Revenue and Forecast to 2028 (US$ Million)

Table 4. China: Insulin Market, by Rapid Acting Insulins – Revenue and Forecast to 2028 (US$ Million)

Table 5. China: Insulin Market, by Short Acting Insulins and Traditional Human Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 6. China: Insulin Market, by Concentrated Insulins and Combination Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 7. China: Insulin Market, by Biosimilar Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 8. Japan: Insulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. Japan: Insulin Market, by Long Acting Insulin – Revenue and Forecast to 2028 (US$ Million)

Table 10. Japan: Insulin Market, by Rapid Acting Insulins – Revenue and Forecast to 2028 (US$ Million)

Table 11. Japan: Insulin Market, by Short Acting Insulins and Traditional Human Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 12. Japan: Insulin Market, by Concentrated Insulins and Combination Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 13. Japan: Insulin Market, by Biosimilar Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 14. India: Insulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 15. India: Insulin Market, by Long Acting Insulin – Revenue and Forecast to 2028 (US$ Million)

Table 16. India: Insulin Market, by Rapid Acting Insulins – Revenue and Forecast to 2028 (US$ Million)

Table 17. India: Insulin Market, by Short Acting Insulins and Traditional Human Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 18. India: Insulin Market, by Concentrated Insulins and Combination Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 19. India: Insulin Market, by Biosimilar Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 20. Australia: Insulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 21. Australia: Insulin Market, by Long Acting Insulin – Revenue and Forecast to 2028 (US$ Million)

Table 22. Australia: Insulin Market, by Rapid Acting Insulins – Revenue and Forecast to 2028 (US$ Million)

Table 23. Australia: Insulin Market, by Short Acting Insulins and Traditional Human Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 24. Australia: Insulin Market, by Concentrated Insulins and Combination Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 25. Australia: Insulin Market, by Biosimilar Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 26. South Korea: Insulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 27. South Korea: Insulin Market, by Long Acting Insulin – Revenue and Forecast to 2028 (US$ Million)

Table 28. South Korea: Insulin Market, by Rapid Acting Insulins – Revenue and Forecast to 2028 (US$ Million)

Table 29. South Korea: Insulin Market, by Short Acting Insulins and Traditional Human Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 30. South Korea: Insulin Market, by Concentrated Insulins and Combination Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 31. South Korea: Insulin Market, by Biosimilar Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 32. Rest of Asia Pacific: Insulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 33. Rest of Asia Pacific: Insulin Market, by Long Acting Insulin – Revenue and Forecast to 2028 (US$ Million)

Table 34. Rest of Asia Pacific: Insulin Market, by Rapid Acting Insulins – Revenue and Forecast to 2028 (US$ Million)

Table 35. Rest of Asia Pacific: Insulin Market, by Short Acting Insulins and Traditional Human Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 36. Rest of Asia Pacific: Insulin Market, by Concentrated Insulins and Combination Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 37. Rest of Asia Pacific: Insulin Market, by Biosimilar Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 38. Organic Developments in the Insulin Market

Table 39. Inorganic Developments in the Insulin Market

Table 40. Glossary of Terms, Insulin Market

LIST OF FIGURES

Figure 1. APAC Insulin Market Segmentation

Figure 2. APAC Insulin Market Segmentation, By Country

Figure 3. APAC Insulin Market Overview

Figure 4. The Long Acting Insulin Segment Held Largest Share of Type in the Insulin Market

Figure 5. Asia-Pacific Is Expected to Show Remarkable Growth During the Forecast Period

Figure 7. Asia Pacific PEST Analysis

Figure 8. Expert Opinion

Figure 9. APAC Insulin Market Impact Analysis of Drivers and Restraints

Figure 10. APAC Insulin Market– Revenue Forecast and Analysis

Figure 11. APAC Insulin Market Revenue Share, by Type (2021 and 2028)

Figure 12. APAC Long Acting Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. APAC Levemir: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. APAC Lantus: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. APAC Basaglar: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. APAC Tresiba: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. APAC Rapid Acting Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. APAC Novolog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. APAC Humalog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. APAC Admelog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. APAC Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. APAC Short Acting Insulins and Traditional Human Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. APAC Novolin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. APAC Humulin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. APAC Insuman: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. APAC Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. APAC Concentrated Insulins and Combination Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. APAC NovoMix: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. APAC Ryzodeg: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. APAC Xultophy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. APAC Soliqua/Suliqua: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. APAC Biosimilar Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. APAC Insulin Glargine: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. APAC Human Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. APAC Glucagon-like peptide-1 (GLP-1): Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. APAC Pens and Needles: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. APAC Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Asia Pacific: Insulin Market, by Key Country – Revenue (2021) (US$ Million)

Figure 39. Asia Pacific: Insulin Market, by Country, 2022 & 2028 (%)

Figure 40. China: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41. Japan: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. India: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. Australia: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44. South Korea: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45. Rest of Asia Pacific: Insulin Market – Revenue and Forecast to 2028 (US$ Million)